TARSONS319.00

Tarsons Products Limited

· Pharma & Health
₹ CrorePeersFISCHERLAXMIDENTLFABTECHGKBMcap ₹1,697 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
TARSONS
FY26
FISCHER
FY26
LAXMIDENTL
FY26
FABTECH
FY26
Peer
Median
Valuation — at last close
P/E118.59×73.33×36.76×14.71×36.76× +223%
P/B2.67×5.99×4.58×1.56×4.58× -42%
EV/EBITDA17.44×54.88×25.26×17.14×25.26× -31%
Market Cap₹1,697 Cr₹2,304 Cr₹1,117 Cr₹654 Cr₹1,117 Cr +52%
Growth
Revenue YoY (latest Q)20.66%249.42%13.87%10.26%13.87% +49%
Net Income YoY (latest Q)-180.99%-24.30%23.83%168.73%23.83% -860%
Profitability
EBITDA Margin27.91%13.96%15.62%8.52%13.96% +100%
Net Income Margin3.39%10.05%10.41%9.34%10.05% -66%
Return on Common Equity2.26%8.05%11.87%9.14%9.14% -75%
Return on Capital Employed2.32%9.71%10.46%6.65%9.71% -76%
Return on Assets1.21%4.62%9.84%5.87%5.87% -79%
Credit & Quality
Total Debt/Equity0.60×0.19×0.00×0.10×0.10× +500%
Interest Coverage0.95×6.87×20.15×7.14×7.14× -87%
Scale — latest FY
Revenue / Total Income₹423 Cr₹309 Cr₹278 Cr₹411 Cr₹309 Cr +37%
Net Income₹14.3 Cr₹31 Cr₹28.9 Cr₹38.4 Cr₹31 Cr -54%
Total Assets₹1,186 Cr₹671 Cr₹294 Cr₹654 Cr₹654 Cr +81%
EPS₹2.69₹0.48₹5.53₹10₹5.53 -51%
Book Value per Share₹119.29₹5.88₹44.42₹94.43₹44.42 +169%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.